QCLSNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Q/C TECHNOLOGIES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.50−0.04 (-7.10%)
Close on Oct 19, 2026
- Market cap
- $4.12M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Nov 19, 2025(first seen in filings) | 1-for-97 reverse | Earlier per-share figures multiplied by 97 |
| Sep 2, 2025 | 1-for-100 reverse | Earlier per-share figures multiplied by 100 |
| Feb 15, 2024 | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |
| Apr 19, 2021 | 1-for-2 reverse | Earlier per-share figures multiplied by 2 |
| Mar 25, 2020(first seen in filings) | 1-for-22.5 reverse | Earlier per-share figures multiplied by 22.5 |
| Nov 25, 2019 | 1-for-24 reverse | Earlier per-share figures multiplied by 24 |
| Nov 14, 2018(first seen in filings) | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |
| Nov 8, 2018 | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |